Charles S. Fuchs's most recent trade in Erasca Inc was a trade of 1,300,000 Stock option (right to buy) done . Disclosure was reported to the exchange on Aug. 10, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Erasca Inc | Charles S. Fuchs | President, R&D | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Aug 2026 | 1,300,000 | 1,300,000 | - | - | Stock option (right to buy) | |
| CytomX Therapeutics Inc | Charles S. Fuchs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jul 2026 | 118,000 | 118,000 | - | - | Stock Option (Right to Buy) |